Myeloma Series CAR T Wang homepage image
CAR-T Cell Trial for Multiple Myeloma to Launch in 2017
March 22, 2017

CAR-T cell therapy research at City of Hope is an innovative and promising approach that recruits the body’s own immune system in the fight against some of the hardest-to-treat cancers, including multiple myeloma.

Myeloma Series Part 2 McNutt Seated
‘Dwindling’ ribs, failing kidneys: How one woman climbed back from myeloma
March 21, 2017

Hypercalcemia (high blood calcium), renal problems, anemia and bone problems, also known by the acronym, C.R.A.B. — reflects the typical symptoms of multiple myeloma. City of Hope follows a multiple myeloma patient, Donna McNutt, who finds ways to cope with her diagnosis.

City of Hope elects three distinguished business leaders to its board of directors
March 20, 2017

City of Hope, a world-renowned independent research and treatment center for cancer and diabetes, today announced three new members to its board of directors: Barbara Bruser, senior managing director with First Republic Private Wealth Management, Steven B. Fink, former chief executive officer of Lawrence Investments LLC, and William J. Post, chairman of the board of Translational Genomics Research Institute (TGen).

Myeloma Series _ Cangin_White BG
'I had this monster that was in me': Coping with fear of relapse
March 20, 2017

Relapse is one of the most common fears among cancer patients. Nearly 60 percent of cancer survivors are moderately-to-severely concerned about recurrence one year after remission, according to data from the American Cancer Society. City of Hope follows a multiple myeloma patient, Donna McNutt, who finds ways to cope with her fear and anxiety.

Rosen-Steven
Four City of Hope Doctors Earn Coveted Distinction
March 17, 2017

Four City of Hope doctors have been named fellows by the American Society of Clinical Oncology (ASCO), an honor bestowed on fewer than 200 of the organization’s more than 40,000 members.